Zobrazeno 1 - 10
of 298
pro vyhledávání: '"Leslie W. Miller"'
Autor:
Americo Hossne Nelson, Eduardo Cruz, Enio Buffolo, Anna Carolina Teixeira De Siqueira Mac Dowell Coimbra, Janaina Machado, Regina Coeli Dos Santos Goldenberg, Germana Regazzi, Silvia Azevedo, Adriana Luckow Invitti, João Nelson Rodrigues Branco, José Salvador Rodrigues De Oliveira, Noedir Antonio Groppo Stolf, Leslie W. Miller, Paul R. Sanberg
Publikováno v:
Cell Transplantation, Vol 24 (2015)
Mononuclear stem cells have been studied for their potential in myocardial ischemia. In our previous published article, ReACT ® phase I/II clinical trial, our results suggest that a certain cell population, promonocytes, directly correlated with the
Externí odkaz:
https://doaj.org/article/9dfe726f77ba4d32873a1c1485d6c96c
Autor:
Emerson C. Perin, Kenneth M. Borow, Timothy D. Henry, Farrell O. Mendelsohn, Leslie W. Miller, Elizabeth Swiggum, Eric D. Adler, David H. Chang, R. David Fish, Alain Bouchard, Margaret Jenkins, Alex Yaroshinsky, Jack Hayes, Olga Rutman, Christopher W. James, Eric Rose, Silviu Itescu, Barry Greenberg
Publikováno v:
Journal of the American College of Cardiology. 81:849-863
Autor:
Timothy D. Henry, Saihari Sadanandan, Mehdi H. Shishehbor, Vikram S. Kashyap, Joseph M. Pastore, Leslie W. Miller, Parag D Patel, Tarek A Hammad, Matthew C. Bunte, John H. Rundback, Michael L. Fitzgerald
Publikováno v:
Journal of Endovascular Therapy. 27:669-675
Purpose: To present the 6-month results of the Stromal Cell–Derived Factor-1 Plasmid Treatment for Patients with Peripheral Artery Disease (STOP-PAD) trial. The trial was an attempt to alter the course of chronic limb-threatening ischemia (CLTI) wi
Publikováno v:
Circulation Research. 124:1658-1678
There are only 2 treatments for the thousands of patients who progress to the most advanced form of heart failure despite the application of guideline-based medical therapy, use of ventricular assist devices and heart transplantation. There has been
Autor:
Emerson C. Perin, Thomas J. Povsic, Leslie W. Miller, Andreas M. Zeiher, Douglas W. Losordo, Francisco Fernández-Avilés, Mitchell W. Krucoff, Doris A. Taylor, Jonathan H. Seltzer, Alexander C. Fanaroff, Valarie Morrow, Timothy D. Henry
Publikováno v:
Circulation Research. 123:495-505
Although clinical trials of cell-based approaches to cardiovascular disease have yielded some promising results, no cell-based therapy has achieved regulatory approval for a cardiovascular indication. To broadly assess the challenges to regulatory ap
Autor:
Leslie W. Miller
Publikováno v:
Journal of the American College of Cardiology. 71:439-442
Publikováno v:
Cardiovascular Revascularization Medicine. 28:S25
Autor:
Leslie W. Miller
Publikováno v:
Journal of the American College of Cardiology. 72:602-604
Autor:
Leslie W. Miller
Publikováno v:
Global Cardiology Science & Practice
Cardiovascular disease (CVD) remains the leading cause of death as well as morbidity in the world. While there has been continued progress in reducing the mortality of most forms of CVD, the prevalence, as well as mortality and morbidity from heart f
Autor:
Leslie W. Miller
Publikováno v:
Journal of the American College of Cardiology. 67:1881-1884
Despite the marked reduction in mortality from acute myocardial infarction (AMI), which may be as low as 3% to 4% with today’s national guidelines for rapid, catheter-based revascularization to open the infarct-related artery, cardiogenic shock rem